More than 30 million people in the US are now taking GLP-1 drugs, with many reporting significant weight loss and improved health. Carly Anderson, a former elementary school teacher, is one of them – she lost 40 pounds and her chronic joint pain disappeared after starting the medication.

Anderson’s story is not unique – many people are turning to GLP-1s for weight loss and to improve related health issues. The drugs were initially approved 20 years ago to treat diabetes, but researchers noticed that patients were also losing weight. Now, there are over a dozen approved GLP-1 drugs, with more on the way.

GLP-1 Drugs and Weight Loss

Yale endocrinologist Dr. Ania Jastreboff says GLP-1s are transforming her patients’ lives, allowing them to be more active and healthy. She believes that treating obesity early can prevent and mitigate hundreds of other diseases, including high blood pressure and diabetes.

While the results are promising, there are potential side effects to consider, such as gastrointestinal distress and anhedonia, also known as “ozempic personality.” Some patients have reported losing interest in activities they once enjoyed, but this can often be adjusted by changing the medication.

The cost of GLP-1s is also a concern – while Medicare and Medicaid will start covering the drugs this summer, many patients on private insurance cannot afford the weekly injections. Doctors are now studying ways to make the medication more accessible.

Future of GLP-1 Treatment

As more people turn to GLP-1s for weight loss and health improvement, researchers are working to understand the full potential of these drugs. Dr. Jastreboff says that by treating obesity, we may be able to prevent and treat hundreds of other diseases, saving millions of lives.

The impact of GLP-1s on public health could be significant, with obesity rates in the US appearing to decline. As doctors and researchers continue to study and refine GLP-1 treatment, it’s clear that these drugs are playing a major role in the fight against obesity and related health issues.